-
1
-
-
0000419304
-
Agammaglobulinemia
-
Bruton OC: Agammaglobulinemia. Pediatrics 9:722-728, 1952.
-
(1952)
Pediatrics
, vol.9
, pp. 722-728
-
-
Bruton, O.C.1
-
2
-
-
33745139749
-
Comparison of the efficacy and safety of immunoglobulin given subcutaneously versus intravenous immunoglobulin in the prevention of infection in patients with primary antibody deficiency syndromes
-
Björkander J, Chapel H, Spickett G: Comparison of the efficacy and safety of immunoglobulin given subcutaneously versus intravenous immunoglobulin in the prevention of infection in patients with primary antibody deficiency syndromes. Mol Immunol 35:11-12, 1998.
-
(1998)
Mol Immunol
, vol.35
, pp. 11-12
-
-
Björkander, J.1
Chapel, H.2
Spickett, G.3
-
3
-
-
0021218493
-
Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease
-
Cunningham-Rundles C, Siegel F, Smithwick E, Lion-Boule A, Cunningham-Rundles S, O'Malley J: Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101:435-439, 1984.
-
(1984)
Ann Intern Med
, vol.101
, pp. 435-439
-
-
Cunningham-Rundles, C.1
Siegel, F.2
Smithwick, E.3
Lion-Boule, A.4
Cunningham-Rundles, S.5
O'Malley, J.6
-
4
-
-
0022444537
-
Corticosteroids for prevention of adverse reactions to intravenous immune globulin infusions, in hypogammaglobulinemic patients
-
Lederman H, Roifman C, Lavi S, Gelfand E: Corticosteroids for prevention of adverse reactions to intravenous immune globulin infusions, in hypogammaglobulinemic patients. Am J Med 81:443-446, 1986.
-
(1986)
Am J Med
, vol.81
, pp. 443-446
-
-
Lederman, H.1
Roifman, C.2
Lavi, S.3
Gelfand, E.4
-
5
-
-
0029071060
-
Recommendations for off-label use of intravenously administered immunoglobulin preparations
-
University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations
-
Ratko TA, Burnett DA, Foulke GE, Matuszewski KA, Sacher RA: Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations. JAMA 273:1865-1870, 1995.
-
(1995)
JAMA
, vol.273
, pp. 1865-1870
-
-
Ratko, T.A.1
Burnett, D.A.2
Foulke, G.E.3
Matuszewski, K.A.4
Sacher, R.A.5
-
6
-
-
0030069541
-
Complications of intravenous gammaglobulin in neuromuscular and other diseases
-
Bertorini TE, Nance AM, Horner LH, Greene W, Gelfand MS, Jaster JH: Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19:388-391, 1996.
-
(1996)
Muscle Nerve
, vol.19
, pp. 388-391
-
-
Bertorini, T.E.1
Nance, A.M.2
Horner, L.H.3
Greene, W.4
Gelfand, M.S.5
Jaster, J.H.6
-
7
-
-
0029819741
-
Complications of intravenous immune globulin treatment in neurologic disease
-
Brannagan TH, 3rd, Nagle KJ, Lange DJ, Rowland LP: Complications of intravenous immune globulin treatment in neurologic disease. Neurology 47:674-677, 1996.
-
(1996)
Neurology
, vol.47
, pp. 674-677
-
-
Brannagan III, T.H.1
Nagle, K.J.2
Lange, D.J.3
Rowland, L.P.4
-
9
-
-
0018825013
-
Immunoglobulin replacement therapy by slow subcutaneous infusion
-
Berger M, Cupps TR, Fauci AS: Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 93:55-56, 1980
-
(1980)
Ann Intern Med
, vol.93
, pp. 55-56
-
-
Berger, M.1
Cupps, T.R.2
Fauci, A.S.3
-
10
-
-
0034073949
-
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
-
Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J: The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 20:94-100, 2000.
-
(2000)
J Clin Immunol
, vol.20
, pp. 94-100
-
-
Chapel, H.M.1
Spickett, G.P.2
Ericson, D.3
Engl, W.4
Eibl, M.M.5
Bjorkander, J.6
-
11
-
-
0025738608
-
Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
-
Gardulf A, Hammarstrom L, Smith CI: Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 338:162-166, 1991
-
(1991)
Lancet
, vol.338
, pp. 162-166
-
-
Gardulf, A.1
Hammarstrom, L.2
Smith, C.I.3
-
12
-
-
0027180544
-
The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions
-
Gardulf A, Bjorvell H, Gustafson R, Hammarstrom L, Smith CI: The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 92:200-204, 1993.
-
(1993)
Clin Exp Immunol
, vol.92
, pp. 200-204
-
-
Gardulf, A.1
Bjorvell, H.2
Gustafson, R.3
Hammarstrom, L.4
Smith, C.I.5
-
13
-
-
0029786174
-
Subcutaneous administration of immunoglobulins: What are the advantages?
-
Gardulf A, Hammarstrom L: Subcutaneous administration of immunoglobulins: What are the advantages? Clin Immunother 6:108-116, 1996.
-
(1996)
Clin Immunother
, vol.6
, pp. 108-116
-
-
Gardulf, A.1
Hammarstrom, L.2
-
14
-
-
0028857579
-
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs
-
Gardulf A, Andersen V, Bjorkander J, Ericson D, Froland SS, Gustafson R, Hammarstrom L, Jacobsen MB, Jonsson E, Moller G, et al.: Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 345:365-369, 1995.
-
(1995)
Lancet
, vol.345
, pp. 365-369
-
-
Gardulf, A.1
Andersen, V.2
Bjorkander, J.3
Ericson, D.4
Froland, S.S.5
Gustafson, R.6
Hammarstrom, L.7
Jacobsen, M.B.8
Jonsson, E.9
Moller, G.10
-
15
-
-
4944262622
-
Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home
-
Gardulf A, Nicolay U, Math D, Asensio O, Bernatowska E, Bock A, Costa-Carvalho BT, Granert C, Haag S, Hernandez D, Kiessling P, Kus J, Matamoros N, Niehues T, Schmidt S, Schulze I, Borte M: Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol 114:936-942, 2004.
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 936-942
-
-
Gardulf, A.1
Nicolay, U.2
Math, D.3
Asensio, O.4
Bernatowska, E.5
Bock, A.6
Costa-Carvalho, B.T.7
Granert, C.8
Haag, S.9
Hernandez, D.10
Kiessling, P.11
Kus, J.12
Matamoros, N.13
Niehues, T.14
Schmidt, S.15
Schulze, I.16
Borte, M.17
-
16
-
-
30944444864
-
Health-related quality of life and treatment satisfaction in north american patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home
-
Nicolay U, Kiessling P, Berger M, Gupta S, Yel L, Roifman CM, Gardulf A, Eichmann F, Haag S, Massion C, Ochs HD: Health-related quality of life and treatment satisfaction in north american patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol 26:65-72, 2006.
-
(2006)
J Clin Immunol
, vol.26
, pp. 65-72
-
-
Nicolay, U.1
Kiessling, P.2
Berger, M.3
Gupta, S.4
Yel, L.5
Roifman, C.M.6
Gardulf, A.7
Eichmann, F.8
Haag, S.9
Massion, C.10
Ochs, H.D.11
-
17
-
-
3543141237
-
Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases
-
Ochs HD, Pinciaro PJ: Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. J Clin Immunol 24:309-314, 2004.
-
(2004)
J Clin Immunol
, vol.24
, pp. 309-314
-
-
Ochs, H.D.1
Pinciaro, P.J.2
-
18
-
-
2942641966
-
Subcutaneous immunoglobulin replacement in primary immunodeficiencies
-
Berger M: Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol 112:1-7, 2004.
-
(2004)
Clin Immunol
, vol.112
, pp. 1-7
-
-
Berger, M.1
-
19
-
-
0035822661
-
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial
-
Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, Strengers PF, Nienhuis H, Schellekens PT: The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 135:165-174, 2001.
-
(2001)
Ann Intern Med
, vol.135
, pp. 165-174
-
-
Eijkhout, H.W.1
Van Der Meer, J.W.2
Kallenberg, C.G.3
Weening, R.S.4
Van Dissel, J.T.5
Sanders, L.A.6
Strengers, P.F.7
Nienhuis, H.8
Schellekens, P.T.9
-
20
-
-
33745040276
-
Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies - A prospective, multi-national study
-
In press
-
Gardulf A, Nicolay U, Asensio O, Bernatowska E, et al.: Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies - a prospective, multi-national study. J Clin Immunol In press, 2006.
-
(2006)
J Clin Immunol
-
-
Gardulf, A.1
Nicolay, U.2
Asensio, O.3
Bernatowska, E.4
-
21
-
-
0029736668
-
Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency
-
Pruzanski W, Sussman G, Dorian W, Van T, Ibanez D, Redelmeier D: Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency. Inflammation 20:353-359, 1996.
-
(1996)
Inflammation
, vol.20
, pp. 353-359
-
-
Pruzanski, W.1
Sussman, G.2
Dorian, W.3
Van, T.4
Ibanez, D.5
Redelmeier, D.6
-
22
-
-
0031871760
-
Immunoglobulin replacement treatment by rapid subcutaneous infusion
-
Gaspar I, Gerritsen B, Jones A: Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 79:48-51, 1998.
-
(1998)
Arch Dis Child
, vol.79
, pp. 48-51
-
-
Gaspar, I.1
Gerritsen, B.2
Jones, A.3
-
23
-
-
0022626952
-
Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA
-
Burks AW, Sampson HA, Buckley RH: Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 314:560-564, 1986.
-
(1986)
N Engl J Med
, vol.314
, pp. 560-564
-
-
Burks, A.W.1
Sampson, H.A.2
Buckley, R.H.3
-
24
-
-
0031802363
-
Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy
-
Sundin U, Nava S, Hammarstrom L: Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 112:341-346, 1998.
-
(1998)
Clin Exp Immunol
, vol.112
, pp. 341-346
-
-
Sundin, U.1
Nava, S.2
Hammarstrom, L.3
-
25
-
-
0141574289
-
Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy
-
Eijkhout HW, van den Broek PJ, van der Meer JW: Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med 61:213-217, 2003.
-
(2003)
Neth J Med
, vol.61
, pp. 213-217
-
-
Eijkhout, H.W.1
Van Den Broek, P.J.2
Van Der Meer, J.W.3
-
26
-
-
3442901469
-
Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases
-
Berger M, Pinciaro PJ: Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases. J Clin Immunol 24:389-396, 2004.
-
(2004)
J Clin Immunol
, vol.24
, pp. 389-396
-
-
Berger, M.1
Pinciaro, P.J.2
-
27
-
-
0021259298
-
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
-
Ochs HD, Fischer SH, Wedgwood RJ, Wara DW, Cowan MJ, Ammann AJ, Saxon A, Budinger MD, Allred RU, Rousell RH: Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med 76:78-82, 1984.
-
(1984)
Am J Med
, vol.76
, pp. 78-82
-
-
Ochs, H.D.1
Fischer, S.H.2
Wedgwood, R.J.3
Wara, D.W.4
Cowan, M.J.5
Ammann, A.J.6
Saxon, A.7
Budinger, M.D.8
Allred, R.U.9
Rousell, R.H.10
-
28
-
-
0030793979
-
Human intravenous immunoglobulin in primary and secondary antibody deficiencies
-
Stiehm ER: Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J 16:696-707, 1997.
-
(1997)
Pediatr Infect Dis J
, vol.16
, pp. 696-707
-
-
Stiehm, E.R.1
|